OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes
Mar 23, 2018 12:00 pm UTC| Business
MIAMI, March 23, 2018 -- OPKO Health, Inc. (NASDAQ:OPK) has enrolled the first patient in a Phase 2b dose escalation trial of OPK88003, a once-weekly oxyntomodulin therapy containing dual agonist activity towards GLP-1...
Route1 Closes the Acquisition of Group Mobile
Mar 23, 2018 12:00 pm UTC| Business
TORONTO, March 23, 2018 -- Route1 Inc. (OTCQB:ROIUF) (TSXV:ROI) (the “Company” or “Route1”), a leader in secure data protection technologies and user authentication for government and enterprise, today announced that it...
Mar 23, 2018 11:55 am UTC| Business
NEW YORK, March 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dime Community...
Mar 23, 2018 11:50 am UTC| Business
Dublin, March 23, 2018 -- The "Personal Protective Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive...
Mar 23, 2018 11:50 am UTC| Business
NEW YORK, March 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of InfraREIT, Inc....
Mar 23, 2018 11:45 am UTC| Business
Dublin, March 23, 2018 -- The "Renewable Chemicals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics...
Mar 23, 2018 11:45 am UTC| Business
NEW YORK, March 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Systemax Inc....